Management of Acute Kidney Injury During Rapid Blood Transfusion

Immediate Actions

The American College of Cardiology recommends immediately stopping the transfusion, assessing volume status, withdrawing all nephrotoxic medications, and determining if the patient has true hypovolemia requiring cautious fluid resuscitation with balanced crystalloids or volume overload requiring diuretic therapy—while closely monitoring for transfusion-associated circulatory overload (TACO) which is the most common cause of AKI during rapid transfusion 1
Rapid blood transfusion can cause volume overload leading to AKI, particularly in patients with pre-existing cardiac or renal dysfunction 1
Immediately discontinue all nephrotoxic agents including NSAIDs, ACE inhibitors, ARBs, aminoglycosides, and contrast agents, as these worsen kidney injury regardless of etiology 1
Withdraw or reduce diuretics temporarily, as they falsely elevate fractional excretion of sodium and can perpetuate volume depletion 1

The key decision point is distinguishing true hypovolemia from volume overload, as indiscriminate fluid administration worsens outcomes 1
Look for clinical signs: jugular venous distension, pulmonary edema, peripheral edema suggest overload; hypotension, tachycardia, poor skin turgor suggest depletion 1
Monitor fluid status closely because of the risk of pulmonary edema with excessive albumin or blood product administration 2

AKI is defined as an increase in serum creatinine ≥0.3 mg/dL within 48 hours or ≥50% increase from baseline within 7 days 4, 5
Perform urine microscopy in all AKI cases to distinguish prerenal from intrinsic causes 1
Obtain renal ultrasound to exclude obstruction 4, 5
Check for proteinuria (>500 mg/day) and microhematuria (>50 RBCs per high-power field) to identify structural kidney injury 4, 5

Measure serum creatinine every 2-4 days during hospitalization to assess AKI progression 1
Check daily for electrolyte abnormalities, particularly potassium >6.0 mEq/L, which represents the most immediately life-threatening complication 1
Maintain strict input/output records, as oliguria (<0.5 mL/kg/h for >6 hours) can indicate need for renal replacement therapy 6

Do not rely on BUN:Cr ratio alone to distinguish prerenal from intrinsic AKI, as it is unreliable 1
Do not use eGFR for medication dosing in AKI—it overestimates true renal function in non-steady state conditions 6, 3

Even if AKI fully "recovers," patients remain at significantly increased long-term risk of recurrent AKI, progression to chronic kidney disease, cardiovascular events, and increased mortality 1
Check creatinine every 2-4 weeks for 6 months post-discharge 1
Refer to nephrology if creatinine fails to return to within 115% of baseline 1
Stage 3 AKI requires earlier and more intensive follow-up than Stage 1 7